Sage Menogen tablets seized; firm settles with Estratest manufacturer Solvay.

Executive Summary

SAGE MENOGEN ESTERIFIED ESTROGENS/METHYLTESTOSTERONE GENERIC TABLETS SEIZED Jan. 9, following a Jan. 5 request for seizure of two lots (approximately 1,061 bottles) of Menogen by Florida U.S. Attorney Thomas Scott. The request for seizure states that the product had been shipped in interstate commerce although "no approvals of applications filed [with FDA] are in effect for such drugs." In addition, as part of a Dec. 8 settlement with Solvay Pharmaceuticals, Sage is enjoined from further manufacturing or marketing of Menogen. Solvay markets Estratest (esterified estrogens and methyltestosterone).